Rallybio Corp

RLYB · Nasdaq · SIC 2834: Pharmaceutical Preparations
79
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Our lead program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. In addition, RLYB332, a long-acting matriptase-2 ("M...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRLYBdiscussed_in_filing Artificial Intelligence
topic_mentionRLYBdiscussed_in_filing Cybersecurity
topic_mentionRLYBdiscussed_in_filing Trusted Computing
topic_mentionRLYBdiscussed_in_filing Blockchain & Crypto
topic_mentionRLYBdiscussed_in_filing Regulation
topic_mentionRLYBdiscussed_in_filing Healthcare & Bio
topic_mentionRLYBdiscussed_in_filing Platform & Ecosystem
topic_mentionRLYBdiscussed_in_filing Sovereign & Government
topic_mentionRLYBdiscussed_in_filing Artificial Intelligence
topic_mentionRLYBdiscussed_in_filing Cybersecurity
topic_mentionRLYBdiscussed_in_filing Trusted Computing
topic_mentionRLYBdiscussed_in_filing Blockchain & Crypto
topic_mentionRLYBdiscussed_in_filing Regulation
topic_mentionRLYBdiscussed_in_filing Healthcare & Bio
topic_mentionRLYBdiscussed_in_filing Platform & Ecosystem
topic_mentionRLYBdiscussed_in_filing Sovereign & Government
topic_mentionRLYBdiscussed_in_filing Artificial Intelligence
topic_mentionRLYBdiscussed_in_filing Cybersecurity
topic_mentionRLYBdiscussed_in_filing Trusted Computing
topic_mentionRLYBdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001628280-26-018261EDGAR108K words
2025-03-132024-12-310001739410-25-000040EDGAR
2024-03-122023-12-310001739410-24-000035EDGAR
2023-03-062022-12-310000950170-23-006264EDGAR
2022-03-152021-12-310000950170-22-003767EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001739410-25-000132EDGAR54K words
2025-08-072025-06-300001739410-25-000112EDGAR
2025-05-082025-03-310001739410-25-000061EDGAR
2024-11-072024-09-300001739410-24-000136EDGAR
2024-08-082024-06-300001739410-24-000115EDGAR
2024-05-092024-03-310001739410-24-000057EDGAR
2023-11-092023-09-300001739410-23-000014EDGAR
2023-08-082023-06-300001739410-23-000007EDGAR
2023-05-092023-03-310000950170-23-019165EDGAR
2022-11-072022-09-300000950170-22-022342EDGAR
2022-08-082022-06-300000950170-22-015571EDGAR
2022-05-102022-03-310000950170-22-009013EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001628280-26-022385EDGAR1K words
2026-03-020001193125-26-084444EDGAR
2026-01-290001739410-26-000010EDGAR
2025-11-060001739410-25-000131EDGAR
2025-08-290001193125-25-192749EDGAR
2025-08-070001739410-25-000108EDGAR
2025-07-080001739410-25-000100EDGAR
2025-06-270001739410-25-000093EDGAR
2025-05-160001739410-25-000089EDGAR
2025-05-080001739410-25-000059EDGAR

79 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001739410
TickerRLYB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9c0011eb876d2a22070b50d445b0a7f1e08cb9ac0dd664e10fdace7bdd1db8d0
parent: 9dfc534ce40ac5b22fc7bd0e965e49fc1126ed769b39f44be48ad4ce171fd21d
content hash: 609aed5264782c21dbc124e36ac80a5e8528e1ab8bcecf67e05c94f550d5cfec
signed: 2026-04-13T04:47:12.926Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf